Epidemiological factors influencing the emergence of antimicrobial resistance
- PMID: 9189644
Epidemiological factors influencing the emergence of antimicrobial resistance
Abstract
Antimicrobial resistance is becoming an important public health problem for both hospital- and community-acquired infections. In the hospital, infections caused by drug-resistant Staphylococcus aureus, Mycobacterium tuberculosis, enterococci, and a variety of Gram-negative rods are resulting in increased morbidity, mortality and costs, in part because of prolonged hospitalization and the use of more expensive antimicrobial agents. Drug-resistant, community-acquired infections are also causing important problems in both the developed and the developing world. Although the relative importance of specific pathogens varies with the geographical area, community-acquired pathogens including Salmonella, Shigella, Neisseria gonorrhoeae, Haemophilus influenzae and Streptococcus pneumoniae are causing both sporadic cases and outbreaks of drug-resistant illness. The emergence of antimicrobial resistance is being attributed to a series of societal, technological, environmental and microbial changes. These include increasing populations of susceptible hosts, international travel and commerce, changes in technology and industry, microbial adaptation and change, and the breakdown of public health measures. Addressing emerging problems and antimicrobial resistance will require enhanced surveillance, prudent use of existing antimicrobial drugs, development of new antimicrobial agents, increased emphasis on infection control and hygienic practices, effective disease control programs, better use of existing vaccines, and development of more and better vaccines.
Similar articles
-
Increasing prevalence of antimicrobial resistance among organisms isolated from blood culture in a Singapore hospital.Southeast Asian J Trop Med Public Health. 1994 Mar;25(1):116-22. Southeast Asian J Trop Med Public Health. 1994. PMID: 7825001
-
Antimicrobial-resistant bacteria in the community setting.Nat Rev Microbiol. 2006 Jan;4(1):36-45. doi: 10.1038/nrmicro1325. Nat Rev Microbiol. 2006. PMID: 16357859 Review.
-
Rational approach to limiting emergence of antimicrobial drug resistance.East Afr Med J. 1997 Mar;74(3):187-9. East Afr Med J. 1997. PMID: 9185420 Review.
-
Antimicrobial activity of tigecycline tested against organisms causing community-acquired respiratory tract infection and nosocomial pneumonia.Diagn Microbiol Infect Dis. 2005 Jul;52(3):187-93. doi: 10.1016/j.diagmicrobio.2005.05.004. Diagn Microbiol Infect Dis. 2005. PMID: 16105563
-
[Development of antituberculous drugs: current status and future prospects].Kekkaku. 2006 Dec;81(12):753-74. Kekkaku. 2006. PMID: 17240921 Review. Japanese.
Cited by
-
A comparison of the bacteria found on the hands of 'homemakers' and neonatal intensive care unit nurses.J Hosp Infect. 2003 Aug;54(4):310-5. doi: 10.1016/s0195-6701(03)00146-4. J Hosp Infect. 2003. PMID: 12919763 Free PMC article.
-
Surveillance of antimicrobial resistance. Centralised surveys to validate routine data offer a practical approach.BMJ. 1998 Sep 5;317(7159):614-5. doi: 10.1136/bmj.317.7159.614. BMJ. 1998. PMID: 9727985 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical